On November 2, 2022 Tessa Therapeutics Ltd. (Tessa), a clinical-stage cell therapy company developing next-generation cancer treatments for hematological malignancies and solid tumors, reported that Thomas Willemsen, President and CEO and Dr. Ivan D. Horak, Chief Medical Officer and Chief Scientific Officer, will present at the Stifel Healthcare Conference 2022 (Press release, Tessa Therapeutics, NOV 2, 2022, View Source [SID1234623202]). The conference is taking place November 15-16, 2022, at Lotte New York Palace Hotel, New York City.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

During the conference, Mr. Willemsen, Dr. Horak and Wilson W. Cheung, Chief Financial Officer, will conduct one-on-one meetings with registered investors, showcasing Tessa’s business and clinical development strategy, recent corporate achievements, and anticipated milestones.